Livio Blasi

1.3k total citations
49 papers, 377 citations indexed

About

Livio Blasi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Livio Blasi has authored 49 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Livio Blasi's work include Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (6 papers). Livio Blasi is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), HER2/EGFR in Cancer Research (8 papers) and Cancer Genomics and Diagnostics (6 papers). Livio Blasi collaborates with scholars based in Italy, Argentina and United States. Livio Blasi's co-authors include L. Castagnetta, Luigi Cavanna, Giuseppe Carruba, C. Aschele, Orazia M. Granata, Giuseppe Cicero, Vincenzo Montesarchio, Graziella Pinotti, Luisa Fioretto and Mario Clerico and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of the New York Academy of Sciences.

In The Last Decade

Livio Blasi

43 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Livio Blasi Italy 11 189 89 51 45 38 49 377
Francisco Pedrosa Brazil 15 151 0.8× 68 0.8× 72 1.4× 44 1.0× 36 0.9× 32 673
Liang G. Qu Australia 9 123 0.7× 61 0.7× 43 0.8× 39 0.9× 16 0.4× 32 326
Ligia Fú Honduras 15 284 1.5× 63 0.7× 101 2.0× 27 0.6× 27 0.7× 23 866
Annie Yang United States 6 384 2.0× 109 1.2× 56 1.1× 22 0.5× 23 0.6× 14 559
Benjamin Barnes Germany 13 257 1.4× 63 0.7× 52 1.0× 31 0.7× 29 0.8× 29 530
Nesrine Mejri Tunisia 10 126 0.7× 38 0.4× 62 1.2× 54 1.2× 13 0.3× 51 317
Kate A. McBride Australia 11 170 0.9× 42 0.5× 104 2.0× 69 1.5× 19 0.5× 39 453
Mohammed Ibrahim Canada 13 281 1.5× 111 1.2× 43 0.8× 46 1.0× 6 0.2× 42 463
Daniel S. O’Neil United States 13 230 1.2× 35 0.4× 22 0.4× 37 0.8× 37 1.0× 38 401
Fadi El Karak Lebanon 13 225 1.2× 155 1.7× 45 0.9× 49 1.1× 16 0.4× 51 462

Countries citing papers authored by Livio Blasi

Since Specialization
Citations

This map shows the geographic impact of Livio Blasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Livio Blasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Livio Blasi more than expected).

Fields of papers citing papers by Livio Blasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Livio Blasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Livio Blasi. The network helps show where Livio Blasi may publish in the future.

Co-authorship network of co-authors of Livio Blasi

This figure shows the co-authorship network connecting the top 25 collaborators of Livio Blasi. A scholar is included among the top collaborators of Livio Blasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Livio Blasi. Livio Blasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ricciardi, Giuseppina Rosaria Rita, Alessandro Russo, Antonio Russo, et al.. (2025). Efficacy and Safety Analysis of Nab-Paclitaxel Treatment in Elderly Patients with HER-2 Negative Metastatic Breast Cancer: NEREIDE Study. Cancers. 17(13). 2069–2069.
2.
Antonuzzo, Andrea, Silvia Gonella, Livio Blasi, et al.. (2025). Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology. Healthcare. 13(3). 212–212. 1 indexed citations
3.
Cuccia, Francesco, Salvatore D’Alessandro, Vanessa Figlia, et al.. (2025). Stereotactic Body Radiotherapy for the Treatment of Oligometastases Located in the Peritoneum or in the Abdominal Wall: Preliminary Results from a Mono-Institutional Analysis. Journal of Personalized Medicine. 15(7). 312–312.
4.
Cuccia, Francesco, Fatemeh Jafari, Salvatore D’Alessandro, et al.. (2024). Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence. Journal of Personalized Medicine. 14(5). 538–538.
5.
Cuccia, Francesco, Salvatore D’Alessandro, Livio Blasi, Vito Chiàntera, & Giuseppe Ferrera. (2023). The Role of Radiotherapy in the Management of Vaginal Melanoma: A Literature Review with a Focus on the Potential Synergistic Role of Immunotherapy. Journal of Personalized Medicine. 13(7). 1142–1142. 6 indexed citations
6.
Cuccia, Francesco, Salvatore D’Alessandro, Giuseppe Carruba, et al.. (2023). Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience. Journal of Personalized Medicine. 13(7). 1099–1099. 1 indexed citations
7.
Zaniboni, Alberto, Carlo Barone, Maria Banzi, et al.. (2021). Italian Results of the PRECONNECT Study: Safety and Efficacy of Trifluridine/tipiracil in Metastatic Colorectal Cancer. Future Oncology. 17(18). 2315–2324. 6 indexed citations
8.
Santis, Stefano De, Maria Domenica Simone, Sebastiano Mercadante, et al.. (2021). Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain. Cancer Management and Research. Volume 13. 1747–1756. 3 indexed citations
9.
Indini, Alice, Graziella Pinotti, Fabrizio Artioli, et al.. (2021). Management of patients with cancer during the COVID-19 pandemic: The Italian perspective on the second wave. European Journal of Cancer. 148. 112–116. 6 indexed citations
10.
Aschele, C., Maria Emanuela Negru, Alessandro Pastorino, et al.. (2020). Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy. JAMA Oncology. 7(2). 304–304. 16 indexed citations
11.
Verde, Nicla La, Elena Collovà, Livio Blasi, et al.. (2020). Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study. Clinical Breast Cancer. 21(5). e489–e496. 7 indexed citations
12.
Garrone, Ornella, Tommaso Giarratano, Andrea Michelotti, et al.. (2020). 290P From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial. Annals of Oncology. 31. S358–S358.
13.
Meraviglia, Serena, et al.. (2020). Nivolumab in Metastatic Melanoma: Good Efficacy and Tolerability in Elderly Patients. Current Oncology. 27(2). 75–80. 7 indexed citations
14.
Blasi, Livio, et al.. (2018). Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer. Drug Design Development and Therapy. Volume 12. 1769–1775. 18 indexed citations
15.
Cicero, Giuseppe, et al.. (2017). Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel. Anti-Cancer Drugs. 28(9). 1047–1052. 6 indexed citations
16.
Passiglia, Francesco, Alessandro Perez, Angela Listì, et al.. (2017). Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab. Annals of Oncology. 28. ii10–ii11. 2 indexed citations
17.
Orlando, Laura, Francesco Giotta, Vito Lorusso, et al.. (2014). Biweekly Combination of Trastuzumab, Docetaxel and Gemcitabine for HER2-Positive Metastatic Breast Cancer: Results of a Phase II GOIM Study. Future Oncology. 10(5). 725–733. 3 indexed citations
18.
Rosa, A. E. Di, Antonio Epifanio, Angelo Antonini, et al.. (2003). Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson’s disease. Neurological Sciences. 24(3). 174–175. 35 indexed citations
19.
Castagnetta, L., Orazia M. Granata, Lucia M. Polito, et al.. (1994). Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 49(4-6). 351–357. 31 indexed citations
20.
Castagnetta, L., et al.. (1991). Androgen receptor assays in specimens of prostatic tissue obtained by transurethral resection and transvesical adenomectomy. Urological Research. 19(6). 337–341. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Pedrosa Breakdown of academic impact, for papers by Liang G. Qu Breakdown of academic impact, for papers by Ligia Fú Breakdown of academic impact, for papers by Annie Yang Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Nesrine Mejri Breakdown of academic impact, for papers by Kate A. McBride Breakdown of academic impact, for papers by Mohammed Ibrahim Breakdown of academic impact, for papers by Daniel S. O’Neil Breakdown of academic impact, for papers by Fadi El Karak
Rankless by CCL
2026